SCHEMBL28978182

SCHEMBL28978182

CNC(=O)[C@H](Cc1cccc(Br)c1)NC(=O)c1cc(-c2cccc(Br)c2)nn1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ ALPL P05186 1/20 0.50
▸ CTSS P25774 7/20 0.49
▸ CTSB P07858 6/20 0.49
▸ CTSL P07711 6/20 0.49
▸ CTSK P43235 4/20 0.49
▸ POLB P06746 1/20 0.46
▸ PIN1 Q13526 2/20 0.45
▸ KCNJ6 P48051 2/20 0.44
▸ KCNJ5 P48544 2/20 0.44
▸ KCNJ3 P48549 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MMP1 P03956 1/20 0.42
▸ FCER2 P06734 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28978186 1.00 SMN1; SMN2 (0.51) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL30288611 0.96 ALPL (0.47) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL28978158 0.96 ALPL (0.47) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL28978157 0.96 ALPL (0.47) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL30288636 0.95 ALPL (0.53) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL26307813 0.95 ALPL (0.53) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL30288621 0.95 ALPL (0.53) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL26307067 0.95 ALPL (0.53) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL28978153 0.95 ALPL (0.47) SMN1; SMN2MAPTMEN1LMNAHTT
SCHEMBL28978156 0.95 ALPL (0.47) SMN1; SMN2MAPTMEN1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894373-A N-substituted benzylpyrazole derivatives as beta 2 Use of allosteric modulators, antagonists and agonists of the adrenergic receptor 常州大学 2023-04-04 — — CN disclosed
Send feedback